Given the effect of the cooperation of BCL-6 and EZH2 on miR-142-3p/5p expression in CD4+ T cells in lupus, we wondered whether EZH2 could be a therapeutic target for lupus treatment. Here, BCL6 is linked to systemic lupus erythematosus.